Evaluation of Facebook as a Longitudinal Data Source for Parkinson’s Disease Insights

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background/Objectives: Parkinson’s disease (PD) is a neurodegenerative disorder with a prolonged prodromal phase and progressive symptom burden. Traditional monitoring relies on clinical visits post-diagnosis, limiting the ability to capture early symptoms and real-world disease progression outside structured assessments. Social media provides an alternative source of longitudinal, patient-driven data, offering an opportunity to analyze both pre-diagnostic experiences and later disease manifestations. This study evaluates the feasibility of using Facebook to analyze PD-related discourse and disease timelines. Methods: Participants (N=60) diagnosed with PD, essential tremor, or atypical parkinsonism, along with caregivers, were recruited. Demographic and clinical data were collected during structured interviews. Participants with Facebook accounts shared their account data. PD-related posts were identified using a Naïve Bayes classifier (recall: 0.86, 95% CI: 0.84–0.88, AUC=0.94) trained on a ground-truth dataset of 6,750 manually labeled posts. Results: Among participants with PD (PwPD), Facebook users were significantly younger but had similar MDS-UPDRS scores and disease duration compared to non-users. Among Facebook users with PD, 90% had accounts before diagnosis, enabling retrospective analysis of pre-diagnostic content. PwPD maintained 14 ± 3 years of Facebook history, including 5 ± 6 years pre-diagnosis. They shared an average of 99 ± 172 PD-related posts, with 24 ± 58 occurring pre-diagnosis. Overall, 69% explicitly referenced PD, and 93% posted about PD-related themes. Conclusions: Facebook is a viable platform for studying PD progression, capturing both early content from the premorbid period and later-stage symptoms. These findings support its potential for disease monitoring at scale.

Article activity feed